secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2025-01-02T23:59:59+00:00
Accession:  0001104659-25-000020
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA announces non-binding discussions to acquire Poolbeg Pharma in all-share deal
--------------------------------------------------------------------------------

- Poolbeg shareholders to receive 0.03 HOOKIPA shares per share; expected ~55% ownership of combined entity before planned $30M fundraise.
- Combined group to be Nasdaq-listed with operations in EU, UK, and US; Poolbeg to delist from AIM.
- CVR for HOOKIPA shareholders tied to Gilead milestones (up to $407.5M) and HB-200 proceeds.
- PUSU deadline under UK Takeover Code set for 30 January 2025; no certainty a firm offer will be made.
- Fundraise of up to $30M to extend cash runway through year-end 2026, concurrent with deal completion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465925000020/0001104659-25-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465925000020/tm2432355d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer